This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
Get essential year-end tax filing guidance for DRIP ETFs, including records to gather and strategies to reduce liabilities.
24,400 articlesA biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
Ethereum sits around $2,170 as the scaling debate intensifies. Analysts warn that a fragmented L2 path and security c...
Fannie Mae and Freddie Mac unveiled a wave of condo lending changes, aimed at stabilizing costs and risk. The new rul...
A sweeping study finds AI financial tools may simulate emotional states, including addiction-like responses and dread...
Bitcoin and XRP led a crypto rally after a Trump Iran-focused post, with BTC moving higher and XRP testing multi-week...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
Berkshire Hathaway is sitting on an enormous cash reserve. Far from a weakness, that cash pile gives the company dry ...
A surge in AI infrastructure chips has lifted the Philadelphia Semiconductor Index, yet broad market participation is...
Nvidia and Micron are central to AI data centers, but one may be the better buy for your portfolio. This guide breaks...
A bold state move to end prediction markets triggers a rapid federal backlash. The ensuing lawsuit tests boundaries b...
The NHL and CFTC have agreed to study licensed, crypto-backed sports prediction markets under a new memorandum of und...
A major fund recently shed about $20 million worth of Graphic Packaging shares, prompting questions about the company...